Salarius Pharmaceuticals ...

NASDAQ: SLRX · Real-Time Price · USD
5.81
0.05 (0.87%)
At close: Aug 27, 2025, 3:33 PM

Salarius Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-5.58M -12.54M -31.61M -12.77M
Depreciation & Amortization
4.42K 10.05K 6.68K 19.18K
Stock-Based Compensation
273.73K 524.84K 796.8K 559.04K
Other Working Capital
438.14K -193.35K 1.06M 99.66K
Other Non-Cash Items
n/a 130K 10.84M -44.69K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
772.29K -968.33K 2.37M 2.03M
Operating Cash Flow
-4.53M -12.85M -17.6M -10.2M
Capital Expenditures
n/a -3 -1.5M -3
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 3.00 -1.5M n/a
Investing Cash Flow
n/a n/a -1.5M n/a
Debt Repayment
-466.5K -280.92K n/a -477.03K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 1.49M
Financial Cash Flow
1.06M 6.64M 1.99M 28.3M
Net Cash Flow
-3.47M -6.21M -17.11M 18.1M
Free Cash Flow
-4.53M -12.85M -19.1M -10.2M